Usefulness and Safety of Percutaneous Coronary Interventions for Cardiac Transplant Vasculopathy

American Journal of Cardiology

Volumn 97, Issue 8, 2006, Pages 1192-1197

  Tanaka, Koji ^a   Li, Haiyan ^a   Curran, Peter J ^a   Takano, Yuzuru ^a   Arbit, Boris ^a   Currier, Jesse W ^a   Yeatman, Lawrence A ^a   Kobashigawa, Jon A ^a   Tobis, Jonathan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORTHOTOPIC TRANSPLANTATION; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; VASCULAR DISEASE;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; REOPERATION; SIROLIMUS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645734080     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.038     Document Type: Article

References (29)

1. Keogh A.M., Valantine H.A., Hunt S.A., Schroeder J.S., McIntosh N., Oyer P.E., and Stinson E.B. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 11 (1992) 892-901
2. Gao S.Z., Hunt S.A., Schroeder J.S., Alderman E., Hill I.R., and Stinson E.B. Does rapidity of development of transplant coronary artery disease portend a worse prognosis?. J Heart Lung Transplant 13 (1994) 1119-1124
3. Gallo P., Agozzino L., Angelini A., Arbustini E., Bartoloni G., Bernucci P., Bonacina E., Bosman C., Catani G., di Gioia C., et al. Causes of late failure after heart transplantation. a ten-year survey. J Heart Lung Transplant 16 (1997) 1113-1121
4. Gao S.Z., Alderman E.L., Schroeder J.S., Silverman J.F., and Hunt S.A. Accelerated coronary vascular disease in the heart transplant patient. coronary arteriographic findings. J Am Coll Cardiol 12 (1988) 334-340
5. Kobashigawa J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?. Curr Control Trials Cardiovasc med 1 (2000) 166-171
6. Srivastava R., Keck B.M., Bennett L.E., and Hosenpud J.D. The results of cardiac retransplantation. an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation 70 (2000) 606-612
7. Musci M., Pasic M., Meyer R., Loebe M., Wellnhofer E., Weng Y., Kuppe H., and Hetzer R. Coronary artery bypass grafting after orthotopic heart transplantation. Eur J Cardiothorac Surg 16 (1999) 163-168
8. Kobashigawa J.A., Katznelson S., Laks H., Johnson J.A., Yeatman L., Wang X.M., Chia D., Terasaki P.I., Sabad A., Cogert G.A., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
9. Maggard M.A., Johnson C., Wang T., Terasaki P., Kupiec-Weglinski J.W., Busuttil R.W., and Imagawa D.K. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response. Transplant Proc 31 (1999) 728-729
10. Maggard M.A., Ke B., Wang T., Kaldas F., Seu P., Busuttil R.W., and Imagawa D.K. Effects of pravastatin on chronic rejection of rat cardiac allografts. Transplantation 65 (1998) 149-155
11. Wenke K., Meiser B., Thiery J., Nagel D., von Scheidt W., Steinbeck G., Seidel D., and Reichart B. Simvastatin reduces graft vessel disease and mortality after heart transplantation. a four-year randomized trial. Circulation 96 (1997) 1398-1402
12. Sandhu J.S., Uretsky B.F., Reddy P.S., Denys B.G., Ruffner R.J., Breisblatt W.M., Zerbe T.R., Kormos R.L., Armitage J.M., Hardesty R.L., et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol 69 (1992) 1234-1237
13. Christensen B.V., Meyer S.M., Iacarella C.L., Kubo S.H., and Wilson R.F. Coronary angioplasty in heart transplant recipients. a quantitative angiographic long-term follow-up study. J Heart Lung Transplant 13 (1994) 212-220
14. Halle III A.A., DiSciascio G., Massin E.K., Wilson R.F., Johnson M.R., Sullivan H.J., Bourge R.C., Kleiman N.S., Miller L.W., Aversano T.R., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26 (1995) 120-128
15. Johnson T.H., Das G.S., McGinn A.L., Christensen B.V., Meyer S.M., and Wilson R.F. Physiologic assessment of the coronary collateral circulation in transplanted human hearts. J Heart Lung Transplant 13 (1994) 840-846
16. von Scheidt W., Uberfuhr P., Reichart B., and Steinbeck G. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc 27 (1995) 1936-1938
17. Redonnet M., Tron C., Koning R., Bouchart F., Cribier A., Soyer R., and Bessou J.P. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc 32 (2000) 463-465
18. Keogh A., Richardson M., Ruygrok P., Spratt P., Galbraith A., O'Driscoll G., MacDonald P., Esmore D., Muller D., and Faddy S. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years. a randomized clinical trial. Circulation 110 (2004) 2694-2700
19. Mancini D., Pinney S., Burkhoff D., LaManca J., Itescu S., Burke E., Edwards N., Oz M., and Marks A.R. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108 (2003) 48-53
20. Ryan T.J., Bauman W.B., Kennedy J.W., Kereiakes D.J., King III S.B., McCallister B.D., Smith Jr. S.C., and Ullyot D.J. Guidelines for percutaneous transluminal coronary angioplasty. a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 88 (1993) 2987-3007
21. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., Zerbe A., and Heart Rejection Study Group. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. the International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587-593
22. Uretsky B.F., Murali S., Reddy P.S., Rabin B., Lee A., Griffith B.P., Hardesty R.L., Trento A., and Bahnson H.T. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76 (1987) 827-834
23. Ratkovec R.M., Wray R.B., Renlund D.G., O'Connell J.B., Bristow M.R., Gay Jr. W.A., Karwande S.V., Doty D.B., Millar R.C., Menlove R.L., et al. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg 100 (1990) 6-12
24. Pennock J.L., Oyer P.E., Reitz B.A., Jamieson S.W., Bieber C.P., Wallwork J., Stinson E.B., and Shumway N.E. Cardiac transplantation in perspective for the future. survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg 83 (1982) 168-177
25. Barnhart G.R., Pascoe E.A., Mills A.S., Szentpetery S., Eich D.M., Mohanakumar T., Hastillo A., Thompson J.A., Hess M.L., and Lower R.R. Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev (Orlando) 1 (1987) 31-46
26. Jain S.P., Ramee S.R., White C.J., Mehra M.R., Ventura H.O., Zhang S., Jenkins J.S., and Collins T.J. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol 32 (1998) 1636-1640
27. Sharifi M., Siraj Y., O'Donnell J., and Pompili V.J. Coronary angioplasty and stenting in orthotopic heart transplants. a fruitful act or a futile attempt?. Angiology 51 (2000) 809-815
28. Wong P.M., Piamsomboon C., Mathur A., Chastain II H.D., Singh D.J., Liu M.W., Parks J.M., Iyer S., Dean L.S., Baxley W.A., Bourge R.C., and Roubin G.S. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 82 (1998) 239-241
29. Boffa G.M., Livi U., Grassi G., Casarotto D., Isabella G., Cardaioli P., Panfili M., and Chioin R. Angiographic presentation of coronary artery spasm in heart transplant recipients. Int J Cardiol 73 (2000) 67-74